Antonio Carlos Weston

Antonio Carlos Weston

Auto-generated profile, based on publicly available information

Antonio Carlos Weston

Santa Casa de Porto Alegre, Brazil

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo)
Verified
Journal Article
Open access
PDF file
LBLeandro Cardoso Barchi
Leandro Cardoso Barchi
Marcus F. Kodama P. RamosMarcus F. Kodama P. Ramos
Marcus F. Kodama P. Ramos
ADAndré Roncon Dias
André Roncon Dias
NANelson Adami Andreollo
Nelson Adami Andreollo
AWAntônio Carlos Weston
Antônio Carlos Weston
WJWilson Rodrigues de Freitas Júnior
Wilson Rodrigues de Freitas Júnior
Background: Since the publication of the first Brazilian Consensus on Gastric Cancer (GC) in 2012 carried out by the Brazilian Gastric Cancer Association, new concepts on diagnosis, staging, treatment and follow-up have been incorporated. Aim: This new consensus is to promote an update to professionals working in the fight against GC and to provide guidelines for the management of patients with this condition. Methods: Fifty-nine experts answered 67 statements regarding the diagnosis, staging, treatment and prognosis of GC with five possible alternatives: 1) fully agree; 2) partially agree; 3) undecided; 4) disagree and 5) strongly disagree A consensus was adopted when at least 80% of the sum of the answers “fully agree” and “partially agree” was reached. This article presents only the responses of the participating experts. Comments on each statement, as well as a literature review, will be presented in future publications. Results: Of the 67 statements, there was consensus in 50 (74%). In 10 declarations, there was 100% agreement. Conclusion: The gastric cancer treatment has evolved considerably in recent years. This consensus gathers consolidated principles in the last decades, new knowledge acquired recently, as well as promising perspectives on the management of this disease.

1 December 2013 in Arquivos de Gastroenterologia
Verified
Journal Article
Open access
PDF file
ALAlexandre Losekann
Alexandre Losekann
AWAntonio Carlos Weston
Antonio Carlos Weston
LCLuis Alberto de Carli
Luis Alberto de Carli
MEMarilia Bittencourt Espindola
Marilia Bittencourt Espindola
SPSergio Ricardo Pioner
Sergio Ricardo Pioner
GCGabriela Perdomo Coral
Gabriela Perdomo Coral
Key words: Fatty Liver; Liver cirrhosis; Morbid obesity; Bariatric surgery; Iron metabolism disorders

1 January 2021 in ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo)
Verified
Journal Article
Open access
PDF file
LBLeandro Cardoso Barchi
Leandro Cardoso Barchi
Marcus F. Kodama P. RamosMarcus F. Kodama P. Ramos
Marcus F. Kodama P. Ramos
ADAndré Roncon Dias
André Roncon Dias
NFNora Manoukian Forones
Nora Manoukian Forones
MCMarineide Prudêncio de Carvalho
Marineide Prudêncio de Carvalho
WJWilson Rodrigues de Freitas Júnior
Wilson Rodrigues de Freitas Júnior
Background : The II Brazilian Consensus on Gastric Cancer of the Brazilian Gastric Cancer Association BGCA (Part 1) was recently published. On this occasion, countless specialists working in the treatment of this disease expressed their opinion in the face of the statements presented. Aim : To present the BGCA Guidelines (Part 2) regarding indications for surgical treatment, operative techniques, extension of resection and multimodal treatment. Methods: To formulate these guidelines, the authors carried out an extensive and current review regarding each declaration present in the II Consensus, using the Medline/PubMed, Cochrane Library and SciELO databases initially with the following descriptors: gastric cancer, gastrectomy, lymphadenectomy, multimodal treatment. In addition, each statement was classified according to the level of evidence and degree of recommendation. Results : Of the 43 statements present in this study, 11 (25,6%) were classified with level of evidence A, 20 (46,5%) B and 12 (27,9%) C. Regarding the degree of recommendation, 18 (41,9%) statements obtained grade of recommendation 1, 14 (32,6%) 2a, 10 (23,3%) 2b e one (2,3%) 3. Conclusion : The guidelines complement of the guidelines presented here allows surgeons and oncologists who work to combat gastric cancer to offer the best possible treatment, according to the local conditions available.

1 January 2020 in ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo)
Verified
Journal Article
Open access
PDF file
LBLeandro Cardoso Barchi
Leandro Cardoso Barchi
Marcus F. Kodama P. RamosMarcus F. Kodama P. Ramos
Marcus F. Kodama P. Ramos
OYOsmar Kenji Yagi
Osmar Kenji Yagi
DMDonato Roberto Mucerino
Donato Roberto Mucerino
CBClaudio José Caldas Bresciani
Claudio José Caldas Bresciani
WJWilson Rodrigues de Freitas Júnior
Wilson Rodrigues de Freitas Júnior
Background: The II Brazilian Consensus on Gastric Cancer by the Brazilian Gastric Cancer Association (ABCG) was recently published. On this occasion, several experts in gastric cancer expressed their opinion before the statements presented. Aim: To present the ABCG Guidelines (part 1) regarding the diagnosis, staging, endoscopic treatment and follow-up of gastric cancer patients. Methods: To forge these Guidelines, the authors carried out an extensive and current review regarding each statement present in the II Consensus, using the Medline/PubMed, Cochrane Library and SciELO databases with the following descriptors: gastric cancer, staging, endoscopic treatment and follow-up. In addition, each statement was classified according to the level of evidence and degree of recommendation. Results: Of the 24 statements, two (8.3%) were classified with level of evidence A, 11 (45.8%) with B and 11 (45.8%) with C. As for the degree of recommendation, six (25%) statements obtained grade of recommendation 1, nine (37.5%) recommendation 2a, six (25%) 2b and three (12.5%) grade 3. Conclusion: The guidelines presented here are intended to assist professionals working in the fight against gastric cancer with relevant and current information, granting them to be applied in the daily medical practice.

1 January 2020 in ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo)
Verified
Journal Article
Open access
PDF file
Marcus F. Kodama P. RamosMarcus F. Kodama P. Ramos
Marcus F. Kodama P. Ramos
LBLeandro Cardoso Barchi
Leandro Cardoso Barchi
AWAntonio Carlos Weston
Antonio Carlos Weston
BZBruno Zilberstein
Bruno Zilberstein
The mean age of patients diagnosed with gastric cancer is 65 years and about 5% are younger than 45 years3,4. The trend of falling overall incidence of GC is not so observed in young patients which lead to an increase in the proportional incidence of tumors in young people. Tumors in young adults tend to be diffuse, with aggressive behavior, but age alone is not considered a poor prognostic factor. Tumors in young people always raise the possibility of hereditary component; however, less than 3% of gastric tumors are associated with hereditary genetic syndromes. These syndromes include hereditary diffuse gastric cancer (HDGC), Li-Fraumeni, familial adenomatosis polyposis, Lynch and Peutz-Jeghers. Clinical criteria for suspected HDGC diagnosis include: 1) families with two or more GC patients of any age being at least one diffuse type; 2) individuals with diffuse GC under 40 years of age; 3) families diagnosed with at least one case of diffuse GC or breast lobular tumor before age 50. It is noteworthy that the presence of these criteria does not confirm the diagnosis of HDGC, only suggests the search for mutation in these cases.

1 January 2019 in ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo)
Verified
Journal Article
Open access
PDF file
Marcus F. Kodama P. RamosMarcus F. Kodama P. Ramos
Marcus F. Kodama P. Ramos
LBLeandro Cardoso Barchi
Leandro Cardoso Barchi
AWAntonio Carlos Weston
Antonio Carlos Weston
BZBruno Zilberstein
Bruno Zilberstein
Despite this undeniable limitation of initial studies, preliminary results from other centers, as well as our own experience, showed us that the laparoscopic approach to gastric tumors was feasible.(3) The advantages already described of the laparoscopic method, such as lower postoperative pain, earlier recovery and discharge, were maintained. The surgical time was longer, but the most important fact of these initial studies was the certainty that the postoperative complications were equivalent and the early surgical oncological parameters, such as lymph nodes count and surgical margins did not change. These results encouraged us already in 2016 to question whether it was time for a paradigm shift from laparotomic surgery to minimally invasive laparoscopic surgery.(1) Perhaps, at that time we relied on non-ideal and retrospective evidence giving the impression that it might be wishful thinking. However, the results presented in subsequent years of large prospective randomized trials eventually confirmed our initial impression.